Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Signs of Good Perfusion in Low Cardiac Output States

Key Clinical Indicators of Adequate Perfusion

  • The European Society of Cardiology recommends that patients with low cardiac output can maintain adequate tissue perfusion if compensatory mechanisms are functioning, as evidenced by warm extremities, normal mentation, adequate urine output (>0.5 mL/kg/h), normal lactate (<2 mmol/L), and absence of metabolic acidosis 1
  • Patients with good perfusion may exhibit warm peripheries without cyanosis or mottling, normal mental status without confusion or altered mentation, adequate urine output ≥0.5 mL/kg/h for at least 6 hours, and normal blood pressure with systolic BP ≥90 mmHg without vasopressor support 1, 2, 3
  • Laboratory markers of adequate perfusion include lactate ≤2 mmol/L, absence of metabolic acidosis on blood gas analysis, mixed venous oxygen saturation (SvO₂) ≥65% if measured, and normal blood urea nitrogen to creatinine ratio 1, 2, 3

Understanding the Clinical Context

  • The American College of Cardiology recommends that low cardiac output only drives significant organ dysfunction in patients with impending or overt cardiogenic shock, and that systolic BP maintained ≥90 mmHg, warm skin with normal capillary refill, and clear sensorium are indicators of a compensated state 1, 2, 3
  • In a decompensated state, patients may exhibit systolic BP <90 mmHg for >30 minutes despite adequate volume, cold, clammy extremities with peripheral cyanosis, altered mental status, oliguria <0.5 mL/kg/h, and elevated lactate >2 mmol/L 1, 2, 3

Hemodynamic Considerations

  • The European Heart Journal notes that while cardiac index may be reduced (<2.2 L/min/m²), adequate perfusion can be maintained if systemic vascular resistance compensates appropriately 2, 3

Clinical Pitfalls to Avoid

  • The American College of Cardiology explicitly recommends against using inotropes in patients with low cardiac output but adequate perfusion, as evidenced by warm extremities, normal BP, and normal mentation 4, 5

When to Escalate Therapy

  • Aggressive hemodynamic support with inotropes or vasopressors should only be initiated when there is clinical evidence of hypotension with hypoperfusion, despite adequate volume status, as recommended by the American College of Cardiology and the European Society of Cardiology 1, 4, 5

Low Cardiac Output and Its Effects on Peripheral Tissues

Pathophysiologic Mechanisms

  • The European Society of Cardiology defines cardiogenic shock as tissue hypoperfusion with systolic BP <90 mmHg, low urine output, and evidence of peripheral vasoconstriction including cyanosis 6, 7
  • Cardiogenic shock and severe low cardiac output states cause tissue hypoperfusion with end-organ dysfunction, which can manifest as peripheral neurologic symptoms 6, 7
  • Low cardiac output produces clinical signs including cool extremities, narrow pulse pressure, altered mentation, and evidence of peripheral vasoconstriction 8, 9

Clinical Assessment and Diagnosis

  • Look for signs of cardiogenic shock or impending shock: systolic BP <90 mmHg, cool extremities, altered mentation, oliguria, narrow pulse pressure, resting tachycardia 6, 7, 8
  • Assess for end-organ dysfunction: disproportionate elevation of blood urea nitrogen relative to creatinine, altered mental status, peripheral cyanosis 8, 9

Management and Treatment

  • If true cardiogenic shock is present, aggressive hemodynamic support takes priority over addressing peripheral symptoms 6, 7
  • Low cardiac output drives organ dysfunction only in a small subset of patients with impending or overt cardiogenic shock 10
  • The presence of warm extremities and adequate blood pressure essentially excludes severe low output as the cause 10, 8

REFERENCES

10